Higher Serum Retinol Binding Protein 4 May be a Predictor of Weak Metabolic Control in Chinese Patients with Type 2 Diabetes Mellitus

By Wang MN   Han YB   Li Q   Guo L   Yang YM   Wang W   Zhang JC  

The Journal of International Medical Research, Vol. 40, Iss. 4, 2012-07 ,pp. : 1317-1324

Field House Publishing

Access to resources Recommend Favorite

Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitus

By Reyes-Soffer Gissette   Rondon-Clavo Carlos   Ginsberg Henry N  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 9, 2011-06 ,pp. : 1429-1438

Informa Healthcare

Access to resources Recommend Favorite

Effects of Rosiglitazone and Pioglitazone Combined with Metformin on the Prothrombotic State of Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome

By Derosa G   D'Angelo A   Ragonesi PD   Ciccarelli L   Piccinni MN   Pricolo F   Salvadeo S   Montagna L   Gravina A   Ferrari I   Galli S   Paniga S   Cicero AFG  

The Journal of International Medical Research, Vol. 34, Iss. 5, 2006-09 ,pp. : 545-555

Field House Publishing

Access to resources Recommend Favorite

Valsartan Increases Circulating Adiponectin Levels without Changing HOMA-IR in Patients with Type 2 Diabetes Mellitus and Hypertension

By Lee J-M   Kim J-H   Son H-S   Hong E-G   Yu J-M   Han K-A   Min K-W   Chang S-A  

The Journal of International Medical Research, Vol. 38, Iss. 1, 2010-01 ,pp. : 234-241

Field House Publishing

Access to resources Recommend Favorite

Pioglitazone Improves Diabetic Dyslipidaemia in Patients with Type 2 Diabetes Mellitus with or without Lipid-Lowering Therapy

By Schöfl Christof  

Clinical Drug Investigation, Vol. 25, Iss. 5, 2005-01 ,pp. : 341-345

Adis International

Access to resources Recommend Favorite